Thorne et al. demonstrated that the anti-colon cancer effects of pyrvinium were due to its allosteric activation of CK1α and subsequent suppression of Wnt/β-catenin signalling [15]. The gene discussed is CSNK1A1; the disease is colonic neoplasm.